John P. Hamill, SrVP/CFO/Prin Fin & Acct Ofcr: Aprea Therapeutics APRE Buy · Filed 25/12/11

Trade details

Type: Insider buy
Amount: $5,850
Shares · price: 5,000 sh · $1.17 a share
Held after: 27,733 sh
Stock: Aprea Therapeutics APRE
Person: John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
Trade date: 25/12/10
Filed: 25/12/11
Days to filing: 1 days

First buy in 1 years

Since the last buy: 1.2 years
Last buy: 24/10/11
Insiders buying this week: 2 insiders
Holding change: +22.0%

Aprea Therapeutics trades, last 26 weeks

What else happened in Aprea Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/10~01/09

John P. Hamill's recent trades

John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$5,073
5,700 sh
$5,073
Filed 02/02
Traded 01/30
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$123
50 sh
$123
Filed 24/10/16
Traded 24/10/11
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$1,175
450 sh
$1,175
Filed 24/10/15
Traded 24/10/10
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$7,363
1,010 sh
$7,363
Filed 24/03/14
Traded 24/03/13